Investors Hangout Stock Message Boards Logo
  • Home
  • Mailbox
  • Boards
  • Favorites
  • Whats Hot!
  • Login - Join Now!
Generex Biotechnology Corp GNBT
(Total Views: 333)
Posted On: 05/22/2020 12:15:57 PM
Post# of 36566
Posted By: Creekrat
The powers that be in the vaccine world realize that producing any type of coronavirus vaccine is very difficult and dangerous. Every single one that has been tried so far has what's called a paradoxical immune response when the vaccinated person encounters the virus in the wild (not just in a blood sample). The innoculated persons end up with a worse case of the disease than they would have if they were never vaccinated. The latest example of this is the Dengue fever vaccine fiasco in the Phillipines.

So, this is where NGIO might be golden and different from others. We have a different type of vaccine (Joe calls it a complete vaccine), and because of that our vaccine may actually work.

There is a lot of news lately about vaccines being tested by adding the vaccine to blood samples to see if an immune response is generated. That is a first step, but where most fail is the next step, vaccinating a person who doesn't have the disease and seeing what happens when they are exposed. This is what we need, and I hope that NGIO delivers it!













(6)
(0)









  • New Post - Investors HangoutNew Post

  • Public Reply - Investors HangoutPublic Reply

  • Private Reply - Investors HangoutPrivate Reply

  • Board - Investors HangoutBoard

  • More - Investors HangoutMore

  • Keep Post - Investors HangoutKeep Post
  • Report Post - Investors HangoutReport Post
  • Home - Investors HangoutHome
  • Mailbox - Investors HangoutMailbox
  • Boards - Investors HangoutBoards
  • Favorites - Investors HangoutFavorites
  • Whats Hot! - Investors HangoutWhats Hot!
  • Settings - Investors HangoutSettings
  • Login - Investors HangoutLogin
  • Live Site - Investors HangoutLive Site